MeiraGTx officer Stuart Naylor sells 27,659 shares

The weighted-average sale price reflects multiple transactions priced from $10.53 to $10.88 under a Rule 10b5-1 plan adopted December 9, 2025.

Rhea-AI Filing Summary

MeiraGTx Holdings plc (MGTX) Chief Sci Ofcr, Ophthalmology Stuart Naylor sold 27,659 ordinary shares on October 6, 2026, at a weighted average price of $10.64 per share. The sales were made under a Rule 10b5-1 trading plan adopted December 9, 2025; individual sale prices ranged from $10.53 to $10.88. Stuart Naylor held 613,187 ordinary shares directly after the sale.

Insider Trade Summary 10b5-1

Net Seller: 27,659 shares

Net Sell 1 txn

Insider Naylor Stuart

Role CHIEF SCI OFCR, OPHTHALMOLOGY

Sold 27,659 shs ($294K)

Type	Security	Shares	Price	Value
Sale	Ordinary Shares F1, F2, F3	27,659	$10.64	$294K

Holdings After Transaction: Ordinary Shares — 613,187 shares (Direct)

Footnotes (3)

1. F1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 9, 2025.
2. F2. The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $10.53 to $10.88, inclusive.
3. F3. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.

Key Figures

Ordinary shares sold: 27,659 shares Weighted average sale price: $10.64 per share Sale price range: $10.53 to $10.88 per share +2 more

5 metrics

Ordinary shares sold 27,659 shares Sale on October 6, 2026

Weighted average sale price $10.64 per share October 6, 2026 sale

Sale price range $10.53 to $10.88 per share Individual transactions on October 6, 2026

Ordinary shares held after sale 613,187 shares Direct holdings following the October 6, 2026 sale

Trading plan adoption date December 9, 2025 Rule 10b5-1 trading plan

Key Terms

Rule 10b5-1 trading plan, weighted average sales price

2 terms

Rule 10b5-1 trading plan regulatory

"effected pursuant to a Rule 10b5-1 trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

weighted average sales price financial

"reflects the weighted average sales price"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many MGTX shares did Stuart Naylor sell, and at what price?

Stuart Naylor sold 27,659 MeiraGTx Holdings plc ordinary shares on October 6, 2026, at a weighted average of $10.64 per share. The sales were made under a Rule 10b5-1 trading plan adopted December 9, 2025, and individual prices ranged from $10.53 to $10.88.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/06/2026 - 08:53 PM Accepted by SEC EDGAR 10/06/2026 - 08:53 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Naylor Stuart

(Last) (First) (Middle)

655 THIRD AVENUE

SUITE 1115

(Street)

NEW YORK NEW YORK 10017

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MeiraGTx Holdings plc [ MGTX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CHIEF SCI OFCR, OPHTHALMOLOGY

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/06/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	10/06/2026		S(1)		27,659	D	$10.64(2)(3)	613,187	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 9, 2025.

2. The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $10.53 to $10.88, inclusive.

3. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.

	/s/ Richard Giroux, Attorney-in-fact for Stuart Naylor	10/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)